BIOLASE Recognized on Orange County Business Journal's

BIOLASE Recognized on Orange County Business Journal's
Fastest-Growing Public Companies List 
Two-Year Revenue Growth of 58.5% Lands BIOLASE at Number 25 
IRVINE, CA -- (Marketwire) -- 11/08/12 --  BIOLASE, Inc. (NASDAQ:
BIOL), the world's leading dental laser manufacturer and distributor,
ranked 25th in the Orange County Business Journal's 2012
Fastest-Growing Public Companies list. Rankings are based on
percentage revenue growth for the 12-month period ended June 30, 2012
as compared with the 12-month period ended June 30, 2010. BIOLASE
grew 58.5% during this period. 
Federico Pignatelli, Chairman and CEO, said, "We are pleased to have
been recognized by the Orange County Business Journal for our strong
growth over the past two years, reflecting the positive impact of our
many efforts. This includes re-establishing our direct sales force in
North America and the launch of our revolutionary WaterLase iPlus
all-tissue laser. Our 2012 third quarter results show continued
growth in our core WaterLase technology, as well as in our imaging
products. We expect this trend to continue with the launch of our
EPIC 10 diode soft tissue laser, for which we have already generated
a healthy backlog after recent receipt of regulatory clearance." 
Orange County Business Journal Selection and Qualifications
 Each
year, the Orange County Business Journal provides a ranking of the
fastest growing Orange County-based companies that trade on U.S.
exchanges. Rankings for 2012 are determined based on the percentage
of trailing 12-month revenue growth from June 30, 2010, to June 30,
2012. 
Companies must have recorded sales of at least $300,000 for the 12
months ended June 30, 2010. Furthermore, sales for the 12 months
ended June 30, 2012, must represent at least 13% revenue growth as
compared with the two-years prior period. Based on these criteria, 69
companies were included on the 2012 Fastest-Growing Public Companies
list. The Orange County Business Journal compiled the financial data
with the help of Los Angeles-based investment bank B. Riley & Co.,
along with regulatory filings and other sources. 
About BIOLASE, Inc.
 BIOLASE, Inc. is a biomedical company that
develops, manufactures and markets dental lasers and also distributes
and markets dental imaging equipment; products 
that are focused on
technologies that advance the practice of dentistry and medicine at
the molecular level. The Company's laser products incorporate
approximately 290 patented and patent-pending technologies designed
to provide biologically clinically superior performance with less
pain and faster recovery times. Its imaging products provide
cutting-edge technology at competitive prices to deliver the best
results for dentists and patients. BIOLASE's principal products are
dental laser systems that perform a broad range of dental procedures,
including cosmetic and complex surgical applications, and a full line
of dental imaging equipment. BIOLASE has sold more than 20,600
lasers. Other products under development address ophthalmology and
other medical and consumer markets. 
WaterLase(R), iPlus(TM), and EPIC(TM) are trademarks of BIOLASE, Inc. 
For updates and information on WaterLase and laser dentistry, find
BIOLASE online at www.biolase.com, Facebook at
www.facebook.com/biolaseinc, Twitter at twitter.com/biolaseinc, and
YouTube at www.youtube.com/biolasevideos. 
Safe Harbor Statement Under the Private Securities Litigation Reform
Act of 1995
 Statements contained in this press release that refer to
BIOLASE's estimated or anticipated future results or other
non-historical facts are forward-looking statements, as are any
statements in this press release concerning prospects related to
BIOLASE's strategic initiatives, product introductions and
anticipated financial performance. Forward-looking statements can
also be identified through the use of words such as "anticipates,"
"expects," "intends," "plans," "believes," "seeks," "estimates,"
"may," "will," and variations of these words or similar expressions.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which reflect BIOLASE's current
perspective of existing trends and information and speak only as of
the date of this release. Actual results may differ materially from
BIOLASE's current expectations depending upon a number of factors
affecting BIOLASE's business. These factors include, among others,
adverse changes in general economic and market conditions,
competitive factors including but not limited to pricing pressures
and new product introductions, uncertainty of customer acceptance of
new product offerings and market changes, risks associated with
managing the growth of the business, and those other risks and
uncertainties that may be detailed, from time-to-time, in BIOLASE's
reports filed with the SEC. BIOLASE does not undertake any
responsibility to revise or update any forward-looking statements
contained herein.  
For further information, please contact: 
Lisa Wilson 
In-Site Communications, Inc. 
212-759-3929 
 
 
Press spacebar to pause and continue. Press esc to stop.